Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FPC Infusion for IDA in Home Infusion Patients
NCT05110768Phase 2Unknown
- Sponsor
- Rockwell Medical
- Start
- Nov 2021
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of ferric pyrophosphate in iron deficiency anemia (IDA), sponsored by Rockwell Medical. Status: unknown.
02
Drugs
ferric pyrophosphate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT05110768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05110768.